OR WAIT null SECS
In spite of a drug pipeline that produced 34 new drugs moving to the market, U.S. spending on prescription drugs rose a negligible amount in 2011, according to a report from IMS Institute.
Spending on prescriptions reached $320 billion, with an increase of only 0.5% on a real per capita basis and 3.7% on a nominal basis. In spite of this, prescriptions account for roughly 30% of all healthcare spending. Several variables were measured in the study.